AmpliChip CYP450 Test

From WikiMD's WELLNESSPEDIA

AmpliChip CYP450 Test is a diagnostic tool used in the field of pharmacogenomics to determine an individual's genetic makeup in relation to the cytochrome P450 system. This system is responsible for the metabolism of many drugs and can influence an individual's response to certain medications. The AmpliChip CYP450 Test, developed by Roche, is designed to identify variations in two specific genes, CYP2D6 and CYP2C19, which are known to influence drug metabolism.

Overview[edit]

The AmpliChip CYP450 Test is a microarray-based test that uses DNA extracted from a patient's blood sample. The test identifies specific genetic variations in the CYP2D6 and CYP2C19 genes, which are part of the cytochrome P450 system. This system is responsible for metabolizing approximately 25% of all prescription drugs, including medications for depression, cardiovascular disease, and cancer.

Procedure[edit]

The AmpliChip CYP450 Test is performed using a blood sample taken from the patient. The DNA is extracted from the blood and then applied to the AmpliChip microarray. The microarray is then scanned to identify specific genetic variations in the CYP2D6 and CYP2C19 genes.

Clinical Significance[edit]

The results of the AmpliChip CYP450 Test can provide valuable information to healthcare providers about a patient's potential response to certain medications. This can help to guide treatment decisions and potentially avoid adverse drug reactions. For example, individuals with certain genetic variations may metabolize drugs more slowly or more quickly than average, which can affect the drug's efficacy and the risk of side effects.

Limitations[edit]

While the AmpliChip CYP450 Test can provide valuable information about an individual's potential response to certain medications, it is not a substitute for clinical judgment. Healthcare providers must consider other factors, such as the patient's overall health, other medications they are taking, and their lifestyle, when making treatment decisions.

See Also[edit]

References[edit]


Stub icon

This medical article is a stub. You can help WikiMD by expanding the page.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=AmpliChip_CYP450_Test&oldid=6497820"